Patents by Inventor Ted Underiner

Ted Underiner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS
    Publication number: 20110160204
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable salt form thereof, wherein A, L1, R1, R2, R3, R4, R5, R6, and X are as defined herein. The compounds of Formula I have ALK and/or c-Met inhibitory activity, and may be used to treat ALK- or c-Met-mediated disorders or conditions.
    Type: Application
    Filed: February 25, 2011
    Publication date: June 30, 2011
    Applicant: CEPHALON, INC.
    Inventors: Bruce D. Dorsey, Karen L. Milkiewicz, Douglas A. Pippin, Jay P. Theroff, Ted Underiner, Linda Weinberg, Craig A. Zificsak
  • PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS
    Publication number: 20100048576
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable salt form thereof, wherein A, L1, R1, R2, R3, R4, R5, R6, and X are as defined herein. The compounds of Formula I have ALK and/or c-Met inhibitory activity, and may be used to treat ALK- or c-Met-mediated disorders or conditions.
    Type: Application
    Filed: September 24, 2009
    Publication date: February 25, 2010
    Applicant: CEPHALON, INC.
    Inventors: Bruce D. Dorsey, Karen L. Milkiewicz, Douglas A. Pippin, Jay P. Theroff, Ted Underiner, Linda Weinberg, Craig A. Zificsak
  • Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
    Patent number: 7601716
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable salt form thereof, wherein A, L1, R1, R2, R3, R4, R5, R6, and X are as defined herein. The compounds of Formula I have ALK and/or c-Met inhibitory activity, and may be used to treat ALK- or c-Met-mediated disorders or conditions.
    Type: Grant
    Filed: April 30, 2007
    Date of Patent: October 13, 2009
    Assignee: Cephalon, Inc.
    Inventors: Bruce D. Dorsey, Karen L. Milkiewicz, Douglas A. Pippin, Jay P. Theroff, Ted Underiner, Linda Weinberg, Craig A. Zificsak
  • Pyridopyrazines and derivatives thereof as alk and c-Met inhibitors
    Publication number: 20080032972
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable salt form thereof, wherein A, L1, R1, R2, R3, R4, R5, R6, and X are as defined herein. The compounds of Formula I have ALK and/or c-Met inhibitory activity, and may be used to treat ALK- or c-Met-mediated disorders or conditions.
    Type: Application
    Filed: April 30, 2007
    Publication date: February 7, 2008
    Applicant: Cephalon, Inc.
    Inventors: Bruce Dorsey, Karen Milkiewicz, Douglas Pippin, Jay Theroff, Ted Underiner, Linda Weinberg, Craig Zificsak
  • Cyclic substituted fused pyrrolocarbazoles and isoindolones
    Patent number: 7288650
    Abstract: The present invention is directed to cyclic substituted fused pyrrolocarbazoles and isoindolones. The invention also is directed to methods for making and using the cyclic substituted fused pyrrolocarbazoles and isoindolones.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: October 30, 2007
    Assignee: Cephalon, Inc.
    Inventors: Robert L. Hudkins, Dandu R. Reddy, Jasbir Singh, Rabindranath Tripathy, Ted Underiner
  • Cyclic substituted fused pyrrolocarbazoles and isoindolones
    Patent number: 7074793
    Abstract: The present invention is directed to cyclic substituted fused pyrrolocarbazoles and isoindolones. The invention also is directed to methods for making and using the cyclic substituted fused pyrrolocarbazoles and isoindolones.
    Type: Grant
    Filed: January 12, 2004
    Date of Patent: July 11, 2006
    Assignee: Cephalon, Inc.
    Inventors: Robert L. Hudkins, Dandu R. Reddy, Jasbir Singh, Rabindranath Tripathy, Ted Underiner
  • Cyclic substituted fused pyrrolocarbazoles and isoindolones
    Publication number: 20060128780
    Abstract: The present invention is directed to cyclic substituted fused pyrrolocarbazoles and isoindolones. The invention also is directed to methods for making and using the cyclic substituted fused pyrrolocarbazoles and isoindolones.
    Type: Application
    Filed: February 2, 2006
    Publication date: June 15, 2006
    Applicant: Cephalon, Inc.
    Inventors: Robert Hudkins, Dandu Reddy, Jasbir Singh, Rabindranath Tripathy, Ted Underiner
  • Cyclic substituted fused pyrrolocarbazoles and isoindolones
    Patent number: 6841567
    Abstract: The present invention is directed to cyclic substituted fused pyrrolocarbazoles and isoindolones. The invention also is directed to methods for making and using the cyclic substituted fused pyrrolocarbazoles and isoindolones.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: January 11, 2005
    Assignee: Cephalon, Inc.
    Inventors: Robert L. Hudkins, Dandu R. Reddy, Jasbir Singh, Rabindranath Tripathy, Ted Underiner
  • Cyclic substituted fused pyrrolocarbazoles and isoindolones
    Publication number: 20040186157
    Abstract: The present invention is directed to cyclic substituted fused pyrrolocarbazoles and isoindolones. The invention also is directed to methods for making and using the cyclic substituted fused pyrrolocarbazoles and isoindolones.
    Type: Application
    Filed: January 12, 2004
    Publication date: September 23, 2004
    Applicant: Cephalon, Inc.
    Inventors: Robert L. Hudkins, Dandu R. Reddy, Jasbir Singh, Rabindranath Tripathy, Ted Underiner